project id: TCGA-OV; case submitter id: TCGA-24-1920; selected normal wgs: true; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.1; spectrophotometer method: UV Spec; age at index: 74; days to birth: -27042; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 27042; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 298.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.3; longest dimension: 2.0; preservation method: Unknown; shortest dimension: 0.5; sample id: 9674aaad-5429-4db3-8f5f-04a0e2b7c6f9; sample submitter id: TCGA-24-1920-01A; portion id: 0acc2c2f-3c9e-4d3f-bf8e-56db97456040; portion submitter id: TCGA-24-1920-01A-01; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;